Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

4 M&A Targets With Notable Open Interest
Seeking Alpha
Sunday, October 24, 2010 - 1:35pm
tags:
Genzyme, Savient, Seattle Genetics
Trius, Ariad Show Interesting Pipeline Potential
Seeking Alpha
Sunday, October 24, 2010 - 1:33pm
tags:
Trius Therapeutics, Ariad Pharmaceuticals, rapamycin, mTOR inhibitors
Pharma-paid doctors often have spotty records
Charlotte Observer, NC
Sunday, October 24, 2010 - 1:15pm
tags:
physician payments
Sanofi-Aventis Enters Collaboration With Harvard in Effort to Externalize R&D
Seeking Alpha
Sunday, October 24, 2010 - 1:10pm
tags:
Sanofi, R&D
Pfizer’s Big Generics Bet
Seeking Alpha
Sunday, October 24, 2010 - 1:09pm
tags:
Pfizer, generics, Teuto Brasileiro
Arena Obesity Drug Faces Uncertain Future
The Street
Sunday, October 24, 2010 - 1:08pm
tags:
Arena Pharmaceuticals, obesity
Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
PR Newswire
Sunday, October 24, 2010 - 12:49pm
tags:
Optimer, Clostridium Difficile, fidaxomicin
China Biotech Week in Review: Big Week for IPOs
Seeking Alpha
Sunday, October 24, 2010 - 12:46pm
tags:
China, Sihuan, Shanghai Pharmaceutical, ShangPharma, Pfizer, Takeda, Livzon Pharmaceutical, ProMetic Life Sciences
FDA May Rein In Bioequivalence for Critical Dose Drugs
MedPage Today
Saturday, October 23, 2010 - 1:43pm
tags:
FDA, generics, bioequival
Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results
Bradenton Herald, FL
Saturday, October 23, 2010 - 1:34pm
tags:
Pharmaxis, cystic fibrosis, Bronchitol
Dr. Reddy's Q2 FY11 Financial Results
MarketWatch
Saturday, October 23, 2010 - 1:31pm
tags:
Dr Reddy's
India's pharma industry to quadruple by 2020: report
SME Times
Saturday, October 23, 2010 - 1:28pm
tags:
India
Mylan gets US FDA nod for generic version of Mirapex tablets
Pharmabiz
Saturday, October 23, 2010 - 1:26pm
tags:
Mylan, Mirapex, Boehringer Ingelheim, Parkinson's Disease
Fact Sheet Reveals Mexico's Increasing Investment In Biopharmaceutical Sec
Ithaca Journal
Saturday, October 23, 2010 - 1:25pm
tags:
biotech
Warner Chilcott secures FDA OK
Investor's Business Daily
Saturday, October 23, 2010 - 12:46pm
tags:
Warner Chilcott, Lo Loestrin Fe, oral contraceptives, birth control
7 Big Pharma Stocks Near 52-Week Lows
Motley Fool
Saturday, October 23, 2010 - 12:44pm
tags:
JNJ, Novartis, GSK, Sanofi, Amgen, Teva Pharmaceuticals, Eli Lilly
Bristol-Myers gets drug approvals, awaits more
Yahoo/AP
Saturday, October 23, 2010 - 12:42pm
tags:
Bristol-Myers Squibb, pegylated interferon lambda, hepatitis C, Sprycel, chronic myeloid leukemia, Onglyza
Lilly's Diabetes Setbacks May Spur Shopping Spree Beyond Amylin
Bloomberg
Saturday, October 23, 2010 - 12:39pm
tags:
Eli Lilly, diabetes, Amylin, Pfizer, Sanofi, Cephalon
Aastrom Maps Out Pivotal Trial Strategy With Adult Stem Cell Therapy
Motley Fool
Saturday, October 23, 2010 - 12:38pm
tags:
Aastrom, stem cells, critical limb ischemia
Do Teva Pharmaceutical's Margins Make the Grade?
Motley Fool
Saturday, October 23, 2010 - 12:36pm
tags:
Teva Pharmaceuticals, investors

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.